International Clinical Trial: A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERD

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826455) titled 'A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERD' on Sept. 13.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: HK inno.N Corporation

Condition: GERD (Gastroesophageal Reflux Disease)

Intervention: Drug: Tegoprazan 50 mg

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: September 1, 2026

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/study/NCT07826455

Publis...